Transgenic mouse tails - the UK Supreme Court’s decision on enablement and claim breadth.
Dr Penny Gilbert, Partner, Powell Gilbert
Jasper Clube, Senior VP Intellectual Property and Chief Patent Counsel, Kymab
Sidd Kusumakar, Partner, Powell Gilbert
Joel Coles, Senior Associate, Powell Gilbert
In the recent Regeneron v Kymab case the UK Supreme Court reviewed the question of sufficiency (enablement) for claims to classes of products. In doing so it considered whether UK case law was consistent with European Patent Office practice and whether there should be a lower threshold requirement for inventions that could be said to relate to a “principle of general application”.
What are the take home messages from the judgment? How will this decision affect UK claim drafting practice? Is it in line with the EPO approach - if not, why not? The members of the team involved from PG and Kymab will share their views and discuss the impact of this long running "bet the farm” litigation.
Please see live webinar including Q&As here.